Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study

OBJECTIVE: Several molecules are involved in the pathogenesis of a new bone formation in ankylosing spondylitis (AS). The aim of this study was to evaluate the serum levels of sclerostin in patients with AS as a possible biomarker and to investigate any correlations with radiographic damage, disease...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunol Res
Hlavní autoři: Perrotta, Fabio Massimo, Ceccarelli, Fulvia, Barbati, Cristiana, Colasanti, Tania, De Socio, Antonia, Scriffignano, Silvia, Alessandri, Cristiano, Lubrano, Ennio
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5954944/
https://ncbi.nlm.nih.gov/pubmed/29854850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9101964
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky